0000000000-19-010263.txt : 20190725 0000000000-19-010263.hdr.sgml : 20190725 20190624164134 ACCESSION NUMBER: 0000000000-19-010263 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20190624 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: BridgeBio Pharma, Inc. CENTRAL INDEX KEY: 0001743881 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 BUSINESS PHONE: (650) 391-9740 MAIL ADDRESS: STREET 1: 421 KIPLING STREET CITY: PALO ALTO STATE: CA ZIP: 94301 FORMER COMPANY: FORMER CONFORMED NAME: BridgeBio Pharma LLC DATE OF NAME CHANGE: 20180618 PUBLIC REFERENCE ACCESSION NUMBER: 0001193125-19-157100 LETTER 1 filename1.pdf begin 644 filename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filename2.txt June 24, 2019 Neil Kumar, Ph.D. Chief Executive Officer BridgeBio Pharma LLC 421 Kipling Street Palo Alto, CA 94301 Re: BridgeBio Pharma, Inc. Amendment No. 3 to Registration Statement on Form S-1 Filed June 24, 2019 File No. 333-231759 Dear Dr. Kumar: We have reviewed your amended registration statement and have the following comment. In our comment, we may ask you to provide us with information so we may better understand your disclosure. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to the comment, we may have additional comments. Amendment No. 3 to Form S-1 filed on June 24, 2019 Exhibits 1. We note your disclosure on page 250 of your registration statement under the heading "Description of Capital Stock" stating that the forum selection provision in your amended and restated by-laws does not apply to any actions arising under the Securities Act or Exchange Act. Please ensure that the exclusive forum provision in your by-laws states this clearly, or tell us how you will inform investors in future filings that the provision does not apply to any actions arising under the Securities Act or Exchange Act. Neil Kumar, Ph.D. BridgeBio Pharma LLC June 24, 2019 Page 2 You may contact Rolf Sundwall at 202-551-3105 or Mary Mast at 202-551-3613 if you have questions regarding comments on the financial statements and related matters. Please contact Christine Westbrook at 202-551-5019 or Erin Jaskot at 202-551-3442 with any other questions. Sincerely, FirstName LastNameNeil Kumar, Ph.D. Division of Corporation Finance Comapany NameBridgeBio Pharma LLC Office of Healthcare & Insurance June 24, 2019 Page 2 cc: Maggie Wong, Esq. FirstName LastName